Sandro Huenchuguala & Juan Segura-Aguilar. (2024). Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease. MDPI AG.
Chicago Style (17th ed.) CitationSandro Huenchuguala and Juan Segura-Aguilar. Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease. MDPI AG, 2024.
MLA (9th ed.) CitationSandro Huenchuguala and Juan Segura-Aguilar. Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.